Reckitt Benckiser Group (LON:RKT) Upgraded to Outperform at Royal Bank of Canada

Royal Bank of Canada upgraded shares of Reckitt Benckiser Group (LON:RKTGet Rating) to an outperform rating in a research note released on Wednesday, Marketbeat reports. They currently have GBX 7,000 ($86.29) price objective on the stock, up from their prior price objective of GBX 5,900 ($72.73).

Several other equities research analysts have also recently weighed in on RKT. JPMorgan Chase & Co. restated an overweight rating on shares of Reckitt Benckiser Group in a research note on Thursday, May 12th. Morgan Stanley restated an overweight rating on shares of Reckitt Benckiser Group in a research note on Wednesday, May 11th. Deutsche Bank Aktiengesellschaft restated a buy rating and set a GBX 7,200 ($88.76) target price on shares of Reckitt Benckiser Group in a research note on Monday, May 9th. Berenberg Bank increased their price target on Reckitt Benckiser Group from GBX 7,460 ($91.96) to GBX 7,700 ($94.92) and gave the company a buy rating in a research note on Friday, April 29th. Finally, Barclays increased their price target on Reckitt Benckiser Group from GBX 9,100 ($112.18) to GBX 9,300 ($114.64) and gave the company an overweight rating in a research note on Tuesday, May 3rd. Nine research analysts have rated the stock with a buy rating, According to data from MarketBeat, Reckitt Benckiser Group currently has a consensus rating of Buy and a consensus target price of GBX 7,677.78 ($94.65).

Shares of RKT stock opened at GBX 6,242 ($76.95) on Wednesday. The company has a current ratio of 0.62, a quick ratio of 0.40 and a debt-to-equity ratio of 129.26. The stock has a market cap of £44.62 billion and a P/E ratio of -1,387.11. The stock has a 50 day simple moving average of GBX 6,050.19 and a 200 day simple moving average of GBX 6,112.48. Reckitt Benckiser Group has a 1 year low of GBX 4,905.16 ($60.47) and a 1 year high of GBX 6,709 ($82.70).

About Reckitt Benckiser Group (Get Rating)

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading

Analyst Recommendations for Reckitt Benckiser Group (LON:RKT)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.